4//SEC Filing
Seidel-Dugan Cynthia 4
Accession 0000899243-23-001409
CIK 0001785530other
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 9:36 PM ET
Size
10.2 KB
Accession
0000899243-23-001409
Insider Transaction Report
Form 4
Seidel-Dugan Cynthia
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2023-01-03+115,900→ 115,900 totalExercise: $2.05Exp: 2032-12-31→ Common Stock (115,900 underlying)
Footnotes (1)
- [F1]The option was granted on January 3, 2023 with a Vesting Commencement Date of January 1, 2023. The shares underlying the option vest in equal monthly installments over four years, commencing on the date that is one month following the Vesting Commencement Date and vesting monthly thereafter through January 1, 2027.
Issuer
Werewolf Therapeutics, Inc.
CIK 0001785530
Entity typeother
Related Parties
1- filerCIK 0001857799
Filing Metadata
- Form type
- 4
- Filed
- Jan 8, 7:00 PM ET
- Accepted
- Jan 9, 9:36 PM ET
- Size
- 10.2 KB